Our Newark, OH pharmacy re-opened last Friday after moving to a new location within Behavioral Healthcare Partners of Central Ohio, Inc. We’re excited to celebrate our new location and the ability to serve even more of the Newark community!
- Partner Highlights
- Pharmacy Openings
Grand Re-opening: Newark, OH
Jan 28th, 2019
- Behavioral Health
- Clinical Insights
- Treatment
4 things to know about Spravato® (Intranasal esketamine)
On January 21, 2025, the FDA announced the approval of Spravato® nasal spray as a monotherapy treatment for treatment-resistant depression (TRD), making this medication the first and only monotherapy option...
- Art Celebration
- Consumer Stories
- People-first Pharmacy Care
Genoa’s 2024 Art Celebration: Celebrating the healing power of creativity
“I’ve always expressed myself through my art and learned to use my creativity to inspire others”, says Genoa Healthcare 2024 Art Celebration participant Shanelle G. Genoa’s annual Art Celebration invites...
- Behavioral Health
- Clinical Insights
- Treatment
Esketamine: Latest research offers new hope for adolescents with treatment-resistant depression
Adolescents with treatment-resistant depression (TRD) often struggle with a lack of effective treatment options. While ketamine has been shown to help improve outcomes for adults living with major depressive disorder...
- Behavioral Health
- Clinical Insights
- Partnering with Genoa
CMS reporting now required: 4 ways Genoa can help
By Reena Neumann, PharmD, MBA Since January 1, 2024, the Centers for Medicare & Medicaid Services (CMS) has required that clinics provide outcomes data reporting to secure federal funding through...